Alibaba Health Information Technology Limited
ALBBY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $30,598 | $27,027 | $26,763 | $20,578 |
| % Growth | 13.2% | 1% | 30.1% | – |
| Cost of Goods Sold | $23,166 | $21,131 | $21,062 | $16,470 |
| Gross Profit | $7,432 | $5,895 | $5,701 | $4,108 |
| % Margin | 24.3% | 21.8% | 21.3% | 20% |
| R&D Expenses | $720 | $705 | $678 | $729 |
| G&A Expenses | $391 | $360 | $379 | $395 |
| SG&A Expenses | $2,649 | $2,137 | $2,148 | $2,376 |
| Sales & Mktg Exp. | $2,258 | $1,777 | $1,769 | $1,981 |
| Other Operating Expenses | $2,487 | $2,341 | $2,824 | $2,022 |
| Operating Expenses | $5,856 | $5,183 | $5,650 | $5,127 |
| Operating Income | $1,576 | $640 | -$32 | -$1,098 |
| % Margin | 5.2% | 2.4% | -0.1% | -5.3% |
| Other Income/Exp. Net | -$16 | $299 | $583 | $0 |
| Pre-Tax Income | $1,560 | $939 | $551 | -$253 |
| Tax Expense | $128 | $56 | $14 | $13 |
| Net Income | $1,432 | $883 | $536 | -$266 |
| % Margin | 4.7% | 3.3% | 2% | -1.3% |
| EPS | 1.78 | 1.25 | 0.79 | -0.39 |
| % Growth | 42.4% | 58.2% | 302.6% | – |
| EPS Diluted | 1.78 | 1.25 | 0.79 | -0.39 |
| Weighted Avg Shares Out | 804 | 705 | 675 | 674 |
| Weighted Avg Shares Out Dil | 807 | 705 | 677 | 674 |
| Supplemental Information | – | – | – | – |
| Interest Income | $465 | $478 | $332 | $210 |
| Interest Expense | $3 | $6 | $6 | $4 |
| Depreciation & Amortization | $58 | $54 | $27 | $61 |
| EBITDA | $1,620 | $999 | -$24 | -$188 |
| % Margin | 5.3% | 3.7% | -0.1% | -0.9% |